BSX EBITDA Growth
Boston Scientific · EBITDA Growth
BSX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported23.15%period ending
BSX TTM EBITDA YoY % (38.10% → 23.15%)
Year-over-year change
High-resolution chart · PNG
BSX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 23.1537% | |
| 36.1318% | |
| 34.3782% | |
| 34.3767% | |
| 28.884% | |
| 14.2347% | |
| 13.7062% | |
| 12.4887% | |
| 24.3115% | |
| 28.2241% | |
| 24.7199% | |
| 32.496% | |
| 6.7126% | |
| 10.6864% | |
| 9.758% | |
| -5.5723% | |
| 40.5405% | |
| 55.2058% | |
| 85.0954% | |
| 120.4149% | |
| 29.61% | |
| -8.1712% | |
| -38.2873% | |
| -48.636% | |
| -42.6677% | |
| -35.4966% | |
| -14.5567% | |
| -5.1738% | |
| 14.5897% | |
| 37.2539% | |
| 28.7637% | |
| 32.9393% | |
| 27.7316% | |
| 55.9478% | |
| 64.2916% | |
| 135.2718% | |
| 1,006.135% | |
| 86.6762% | |
| 206.7839% | |
| 397.4843% | |
| -67.7228% | |
| 189.6266% | |
| -7.0093% | |
| -84.6377% | |
| -52.7596% | |
| -81.825% | |
| -45.6853% | |
| 31.1787% | |
| 1,087.7778% | |
| 135.3694% | |
| 123.915% | |
| 123.7079% | |
| 103.4234% | |
| -425.1518% | |
| -345.1637% | |
| -315.4045% | |
| -258.5645% | |
| -31.2463% | |
| 956.051% | |
| 189.8256% | |
| 185.9067% | |
| 189.2971% | |
| 59.8465% | |
| -17.1662% | |
| -31.6508% | |
| -34.1429% | |
| 61.5914% | |
| -235.0506% | |
| -247.3367% | |
| -245.6816% | |
| -215.2888% | |
| -22.9078% | |
| -40.597% | |
| -40.0125% | |
| -48.0588% | |
| -19.105% | |
| 51.4467% | |
| 21.9178% | |
| 21.7765% | |
| 22.0588% | |
| -47.5581% | |
| -36.8876% | |
| -20.2741% | |
| -1.0395% | |
| 68.316% | |
| 126.0586% | |
| 112.7582% | |
| 77.7094% | |
| 43.2% | |
| 13.2841% | |
| 7.3012% | |
| -16.1157% | |
| 4.7904% | |
| 3.5669% | |
| -2.293% | |
| 56.6343% | |
| 23.8872% | |
| -1.2579% | |
| -8.2944% | |
| -32.0132% |